Novel cell directed glutaminase inhibitors as chemotherapeutic agents for hematological malignancies

被引：0
|
作者：
Zimmermann, Sarah [1 ]
Gadiano, Alexandra [1 ]
Alt, Jesse [1 ]
Tenora, Lukas [2 ]
Furtmueller, Georg [1 ]
Garrett, Caroline [1 ]
Majer, Pavel [2 ]
Rais, Rana [1 ]
Slusher, Barbara [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
[2] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Prague, Czech Republic
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2017年 / 254卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
318
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Traditional chemotherapeutic agents as selective inhibitors of glutaminase isozymes
    Katt, William P.
    Cerione, Richard A.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [2] Potential of mTOR inhibitors as therapeutic agents in hematological malignancies
    Sankhala, Kamalesh
    Giles, Francis J.
    EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (04) : 399 - 414
  • [3] CHEMOTHERAPEUTIC AGENTS IN CHILDHOOD MALIGNANCIES
    CHING, LT
    BURGERT, EO
    MILLS, SD
    MAYO CLINIC PROCEEDINGS, 1970, 45 (01) : 36 - +
  • [4] Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological Malignancies
    Biniecka, Paulina
    Matsumoto, Saki
    Belotti, Axel
    Joussot, Jessie
    Bai, Jian Fei
    Majjigapu, Somi Reddy
    Thoueille, Paul
    Spaggiari, Dany
    Desfontaine, Vincent
    Piacente, Francesco
    Bruzzone, Santina
    Cea, Michele
    Decosterd, Laurent A. A.
    Vogel, Pierre
    Nencioni, Alessio
    Duchosal, Michel A. A.
    Nahimana, Aimable
    MOLECULES, 2023, 28 (04):
  • [5] Radiotheranostic Agents in Hematological Malignancies
    Caers, Jo
    Duray, Elodie
    Vrancken, Louise
    Marcion, Guillaume
    Bocuzzi, Valentina
    De Veirman, Kim
    Krasniqi, Ahmet
    Lejeune, Margaux
    Withofs, Nadia
    Devoogdt, Nick
    Dumoulin, Mireille
    Karlstrom, Amelie Eriksson
    D'Huyvetter, Matthias
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [6] Checkpoint inhibitors in hematological malignancies
    Ok, Chi Young
    Young, Ken H.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
  • [7] Checkpoint inhibitors in hematological malignancies
    Chi Young Ok
    Ken H. Young
    Journal of Hematology & Oncology, 10
  • [8] Site-directed irreversible inhibitors of the erbB family of receptor tyrosine kinases as novel chemotherapeutic agents for cancer
    Fry, DW
    ANTI-CANCER DRUG DESIGN, 2000, 15 (01): : 3 - 16
  • [9] Inhibitors of calpain as novel chemotherapeutic agents for prostate cancer.
    Eilon, GF
    Gu, J
    Hara, K
    Jacobs, JW
    CLINICAL CANCER RESEARCH, 1999, 5 : 3789S - 3789S
  • [10] Hsp90 inhibitors as novel cancer chemotherapeutic agents
    Neckers, L
    TRENDS IN MOLECULAR MEDICINE, 2002, 8 (04) : S55 - S61
12345